KeyBank National Association’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,217
Closed -$195K 1181
2024
Q3
$195K Sell
10,217
-12,747
-56% -$264K ﹤0.01% 1096
2024
Q2
$475K Sell
22,964
-809
-3% -$16.1K ﹤0.01% 764
2024
Q1
$447K Sell
23,773
-554
-2% -$9.51K ﹤0.01% 781
2023
Q4
$351K Sell
24,327
-3,074
-11% -$41.8K ﹤0.01% 884
2023
Q3
$476K Sell
27,401
-799
-3% -$16.7K ﹤0.01% 706
2023
Q2
$587K Sell
28,200
-4,285
-13% -$93.1K ﹤0.01% 651
2023
Q1
$764K Sell
32,485
-11,647
-26% -$313K ﹤0.01% 543
2022
Q4
$1.23M Buy
44,132
+8,020
+22% +$205K 0.01% 428
2022
Q3
$845K Sell
36,112
-4,357
-11% -$132K ﹤0.01% 485
2022
Q2
$1.37M Sell
40,469
-8,209
-17% -$288K 0.01% 403
2022
Q1
$1.7M Sell
48,678
-17,492
-26% -$598K 0.01% 401
2021
Q4
$2.02M Sell
66,170
-29,383
-31% -$957K 0.01% 393
2021
Q3
$3.13M Sell
95,553
-42,547
-31% -$1.36M 0.01% 316
2021
Q2
$4.18M Buy
+138,100
New +$4.55M 0.02% 287

Other funds holding OGN

KeyBank National Association's OGN Position: Q4 2024 in Review

KeyBank National Association sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 10,217 shares — an estimated $195K sold.

KeyBank National Association first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $4.18M in Q2 2021. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • KeyBank National Association reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • KeyBank National Association sold 10,217 Organon & Co shares in Q4 2024, an estimated $195K.
  • KeyBank National Association first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
  • KeyBank National Association's Organon & Co position peaked at $4.18M in Q2 2021.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on KeyBank National Association's 13F filing for Q4 2024, filed 6 Feb 2025.